Health professionals have until the end of the month to have their say on the role technology plays in their work.
The Health Foundation, in partnership with CSP and a range of other professional bodies, is researching the impact of technology on the time that clinical staff have available for patient care.
New research for the first time reveals the function of a little-understood junction between cells in the brain that could have important treatment implications for conditions ranging from multiple sclerosis to Alzheimer’s disease, to a type of brain cancer known as glioma.
The study, from Oregon Health & Science University, is published in the journal Nature Neuroscience.
RAZ Mobility has partnered with Amicus Brain to introduce the first AI dementia care advisor to give reliable advice to caregivers.
The company is integrating a conversational AI tool, Amicus Brain’s Dementia Care AI Advisor, into its RAZ Care app, which is used to remotely manage all features of the RAZ Memory Cell Phone.
Precision neurology software and data company, Rune Labs has secured a further $12 million to accelerate the adoption if its novel Parkinson's technology.
This latest round, led by new brain disorder fund, Nexus NeuroTech Ventures, with participation from existing investors, including Eclipse, DigiTx Partners, Moment Ventures and TruVenturo GmbH, brings the total amount raised by the company to over $42 million.
Nexalin Technology has unveiled its new neurostimulation device, which aims to tackle the growing global mental health epidemic through drug-free treatment.
New research provides insight into the severe and incurable form of brain cancer, glioblastoma, and potential therapies to combat treatment resistance.
